Implication of frequency-dependent protocols in antiarrhythmic and proarrhythmic drug testing

Péter P. Nánási, Zoltán Szabó, Kornél Kistamás, Balázs Horváth, László Virág, Norbert Jost, Tamás Bányász, János Almássy, András Varró

Research output: Contribution to journalReview article

Abstract

It has long been known that the electrophysiological effects of many cardioactive drugs strongly depend on the rate dependent frequency. This was recognized first for class I antiarrhythmic agents: their Vmax suppressive effect was attenuated at long cycle lengths. Later many Ca2+ channel blockers were also found to follow such kinetics. The explanation was provided by the modulated and the guarded receptor theories. Regarding the duration of cardiac action potentials (APD) an opposite frequency-dependence was observed, i.e. the drug-induced changes in APD were proportional with the cycle length of stimulation, therefore it was referred as “reverse rate-dependency”. The beat-to-beat, or short term variability of APD (SV) has been recognized as an important proarrhythmic mechanism, its magnitude can be used as an arrhythmia predictor. SV is modulated by several cardioactive agents, however, these drugs modify also APD itself. In order to clear the drug-specific effects on SV from the concomitant unspecific APD-change related ones, the term of “relative variability” was introduced. Relative variability is increased by ion channel blockers that decrease the negative feedback control of APD (i.e. blockers of ICa, IKr and IKs) and also by elevation of cytosolic Ca2+. Cardiac arrhythmias are also often categorized according to the characteristic heart rate (tachy- and bradyarrhythmias). Tachycardia is proarrhythmic primarily due to the concomitant Ca2+ overload causing delayed afterdepolarizations. Early afterdepolarizations (EADs) are complications of the bradycardic heart. What is common in the reverse rate-dependent nature of drug action on APD, increased SV and EAD incidence associated with bradycardia.

Original languageEnglish
JournalProgress in biophysics and molecular biology
DOIs
Publication statusAccepted/In press - Jan 1 2019

Fingerprint

pamidronate
Anti-Arrhythmia Agents
Pharmaceutical Preparations
Bradycardia
Tachycardia
Cardiac Arrhythmias
Ion Channels
Action Potentials

Keywords

  • Action potential duration
  • Cardiac arrhythmias
  • Cardiac ion currents
  • Cardiac myocytes
  • Rate-dependent actions
  • Reverse rate-dependency
  • Short term variability
  • Triggered activity

ASJC Scopus subject areas

  • Biophysics
  • Molecular Biology

Cite this

Implication of frequency-dependent protocols in antiarrhythmic and proarrhythmic drug testing. / Nánási, Péter P.; Szabó, Zoltán; Kistamás, Kornél; Horváth, Balázs; Virág, László; Jost, Norbert; Bányász, Tamás; Almássy, János; Varró, András.

In: Progress in biophysics and molecular biology, 01.01.2019.

Research output: Contribution to journalReview article

@article{e1884f14ee1842c59d402601d7acffec,
title = "Implication of frequency-dependent protocols in antiarrhythmic and proarrhythmic drug testing",
abstract = "It has long been known that the electrophysiological effects of many cardioactive drugs strongly depend on the rate dependent frequency. This was recognized first for class I antiarrhythmic agents: their Vmax suppressive effect was attenuated at long cycle lengths. Later many Ca2+ channel blockers were also found to follow such kinetics. The explanation was provided by the modulated and the guarded receptor theories. Regarding the duration of cardiac action potentials (APD) an opposite frequency-dependence was observed, i.e. the drug-induced changes in APD were proportional with the cycle length of stimulation, therefore it was referred as “reverse rate-dependency”. The beat-to-beat, or short term variability of APD (SV) has been recognized as an important proarrhythmic mechanism, its magnitude can be used as an arrhythmia predictor. SV is modulated by several cardioactive agents, however, these drugs modify also APD itself. In order to clear the drug-specific effects on SV from the concomitant unspecific APD-change related ones, the term of “relative variability” was introduced. Relative variability is increased by ion channel blockers that decrease the negative feedback control of APD (i.e. blockers of ICa, IKr and IKs) and also by elevation of cytosolic Ca2+. Cardiac arrhythmias are also often categorized according to the characteristic heart rate (tachy- and bradyarrhythmias). Tachycardia is proarrhythmic primarily due to the concomitant Ca2+ overload causing delayed afterdepolarizations. Early afterdepolarizations (EADs) are complications of the bradycardic heart. What is common in the reverse rate-dependent nature of drug action on APD, increased SV and EAD incidence associated with bradycardia.",
keywords = "Action potential duration, Cardiac arrhythmias, Cardiac ion currents, Cardiac myocytes, Rate-dependent actions, Reverse rate-dependency, Short term variability, Triggered activity",
author = "N{\'a}n{\'a}si, {P{\'e}ter P.} and Zolt{\'a}n Szab{\'o} and Korn{\'e}l Kistam{\'a}s and Bal{\'a}zs Horv{\'a}th and L{\'a}szl{\'o} Vir{\'a}g and Norbert Jost and Tam{\'a}s B{\'a}ny{\'a}sz and J{\'a}nos Alm{\'a}ssy and Andr{\'a}s Varr{\'o}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.pbiomolbio.2019.11.001",
language = "English",
journal = "Progress in Biophysics and Molecular Biology",
issn = "0079-6107",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Implication of frequency-dependent protocols in antiarrhythmic and proarrhythmic drug testing

AU - Nánási, Péter P.

AU - Szabó, Zoltán

AU - Kistamás, Kornél

AU - Horváth, Balázs

AU - Virág, László

AU - Jost, Norbert

AU - Bányász, Tamás

AU - Almássy, János

AU - Varró, András

PY - 2019/1/1

Y1 - 2019/1/1

N2 - It has long been known that the electrophysiological effects of many cardioactive drugs strongly depend on the rate dependent frequency. This was recognized first for class I antiarrhythmic agents: their Vmax suppressive effect was attenuated at long cycle lengths. Later many Ca2+ channel blockers were also found to follow such kinetics. The explanation was provided by the modulated and the guarded receptor theories. Regarding the duration of cardiac action potentials (APD) an opposite frequency-dependence was observed, i.e. the drug-induced changes in APD were proportional with the cycle length of stimulation, therefore it was referred as “reverse rate-dependency”. The beat-to-beat, or short term variability of APD (SV) has been recognized as an important proarrhythmic mechanism, its magnitude can be used as an arrhythmia predictor. SV is modulated by several cardioactive agents, however, these drugs modify also APD itself. In order to clear the drug-specific effects on SV from the concomitant unspecific APD-change related ones, the term of “relative variability” was introduced. Relative variability is increased by ion channel blockers that decrease the negative feedback control of APD (i.e. blockers of ICa, IKr and IKs) and also by elevation of cytosolic Ca2+. Cardiac arrhythmias are also often categorized according to the characteristic heart rate (tachy- and bradyarrhythmias). Tachycardia is proarrhythmic primarily due to the concomitant Ca2+ overload causing delayed afterdepolarizations. Early afterdepolarizations (EADs) are complications of the bradycardic heart. What is common in the reverse rate-dependent nature of drug action on APD, increased SV and EAD incidence associated with bradycardia.

AB - It has long been known that the electrophysiological effects of many cardioactive drugs strongly depend on the rate dependent frequency. This was recognized first for class I antiarrhythmic agents: their Vmax suppressive effect was attenuated at long cycle lengths. Later many Ca2+ channel blockers were also found to follow such kinetics. The explanation was provided by the modulated and the guarded receptor theories. Regarding the duration of cardiac action potentials (APD) an opposite frequency-dependence was observed, i.e. the drug-induced changes in APD were proportional with the cycle length of stimulation, therefore it was referred as “reverse rate-dependency”. The beat-to-beat, or short term variability of APD (SV) has been recognized as an important proarrhythmic mechanism, its magnitude can be used as an arrhythmia predictor. SV is modulated by several cardioactive agents, however, these drugs modify also APD itself. In order to clear the drug-specific effects on SV from the concomitant unspecific APD-change related ones, the term of “relative variability” was introduced. Relative variability is increased by ion channel blockers that decrease the negative feedback control of APD (i.e. blockers of ICa, IKr and IKs) and also by elevation of cytosolic Ca2+. Cardiac arrhythmias are also often categorized according to the characteristic heart rate (tachy- and bradyarrhythmias). Tachycardia is proarrhythmic primarily due to the concomitant Ca2+ overload causing delayed afterdepolarizations. Early afterdepolarizations (EADs) are complications of the bradycardic heart. What is common in the reverse rate-dependent nature of drug action on APD, increased SV and EAD incidence associated with bradycardia.

KW - Action potential duration

KW - Cardiac arrhythmias

KW - Cardiac ion currents

KW - Cardiac myocytes

KW - Rate-dependent actions

KW - Reverse rate-dependency

KW - Short term variability

KW - Triggered activity

UR - http://www.scopus.com/inward/record.url?scp=85075368709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075368709&partnerID=8YFLogxK

U2 - 10.1016/j.pbiomolbio.2019.11.001

DO - 10.1016/j.pbiomolbio.2019.11.001

M3 - Review article

AN - SCOPUS:85075368709

JO - Progress in Biophysics and Molecular Biology

JF - Progress in Biophysics and Molecular Biology

SN - 0079-6107

ER -